6 hasil
FIELD OF THE INVENTION
This invention relates to a method for providing .alpha.-glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a .alpha.-glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c),
FIELD OF THE INVENTION
This invention relates to bio-affecting and body treating compositions, particularly to uses of processing glucosidase inhibitors for cancer chemotherapy and immunoregulation.
BACKGROUND OF THE INVENTION
Acute-transforming retroviruses carry in their genomes specific oncogenes
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as
CROSS-REFERENCE TO RELATED APPLICATION
This application is the U.S. national phase application, pursuant to 35 U.S.C. .sctn.371, of PCT international application Ser. No. PCT/JP2010/051701, filed Feb. 5, 2010, designating the United States, which claims the benefit of Japanese Application No.
TECHNICAL FIELD
The present invention relates to a substance having a physiological activity such as an anti-tumor effect. More particularly, the present invention relates to a novel substance that has increased physiological activity of the aglycone of isoflavones in soybean or the like and